Xin Lang Cai Jing·2025-10-20 01:49Core Viewpoint - Spring Medical has shown significant stock price growth this year, with a 99.04% increase, indicating strong market performance and investor interest [2]. Company Overview - Spring Medical, established on February 12, 1998, and listed on December 30, 2021, specializes in the research, production, and sales of implantable orthopedic medical devices, primarily joint prosthetics and spinal implants [2]. - The company's main products include hip, knee, shoulder, and elbow joint prosthetics, as well as a full range of spinal fixation systems [2]. - The company exports its products to various regions, including Asia, South America, Africa, Oceania, and Europe [2]. - The revenue composition is heavily weighted towards medical device products, accounting for 99.89% of total revenue [2]. Financial Performance - As of June 30, 2025, Spring Medical reported a revenue of 488 million yuan, representing a year-on-year growth of 28.27% [3]. - The net profit attributable to shareholders for the same period was 114 million yuan, reflecting a year-on-year increase of 44.85% [3]. - Cumulative cash dividends since the A-share listing amount to 359 million yuan, with 309 million yuan distributed over the past three years [4]. Shareholder and Market Activity - As of June 30, 2025, the number of shareholders decreased by 17.57% to 5,920, while the average circulating shares per person increased by 341.41% to 48,836 shares [3]. - The stock price increased by 2.13% on October 20, 2023, reaching 25.38 yuan per share, with a total market capitalization of 9.735 billion yuan [1]. - Major shareholders include Ping An Low Carbon Economy Mixed A and Southern Medical Health Flexible Allocation Mixed A, with notable changes in their holdings [4].